NCT05471193

Brief Summary

A large number of different organ functions are recorded in real time for patients who are monitored in an intensive care unit. On the one hand, the measured values collected in this way are used for continuous monitoring of vital parameters, but they are also evaluated several times a day in order to be able to make decisions regarding further diagnostics and therapy. In the first case, threshold values can be defined, and if these are exceeded or fallen short of, the treatment team is automatically alerted. If these limits are set too liberally, then the alert will only indicate an acute risk to the patient, where extensive pathophysiological changes have already occurred. If the limits are chosen too restrictively, then there are frequent false alarms, since the limits are exceeded in most cases due to natural fluctuation, without this having any pathological value. The consequence is a so-called "alarm fatigue", which in the worst case leads to ignoring correct alarms and thus endangers the patients. By design, all of these readings only show the status quo of a patient. It is the task of the treatment team to predict from the course of these readings whether a threatening situation is developing for the patient. For daily clinical practice, it would be better if dangerous changes in vital signs could be predicted. In this case, it would be possible to intervene therapeutically not only when a dangerous situation has arisen, but to try to avert this situation through adequate measures by changing the therapy strategy. In such a case, the treatment team would no longer be confronted with emergency alarms, but could counteract an impending deterioration with a long lead time. The first approaches for detecting a drop in blood pressure, for example, which are based on simple models, are already in clinical use.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,069

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2022

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 12, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 22, 2022

Completed
9 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2022

Completed
Last Updated

August 17, 2022

Status Verified

August 1, 2022

Enrollment Period

2 months

First QC Date

July 12, 2022

Last Update Submit

August 16, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • AUROC for Classification of Instability

    AUROC for Classification of Instability

    2018-03-01 to 2020-10-31

Secondary Outcomes (2)

  • Confusion Matrix

    2018-03-01 to 2020-10-31

  • Descriptive Statistics This outcome measure will compare the individual feature (e. g. height in cm) in one group vs. the other. Significant difference will be described by p-value.

    2018-03-01 to 2020-10-31

Study Arms (2)

Instability

Diagnostic Test: Machine Learning Prediction

No Instability

Diagnostic Test: Machine Learning Prediction

Interventions

Machine Learning Prediction

InstabilityNo Instability

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

As described in the inclusion criteria.

You may qualify if:

  • All adult patients that have been treated at the intensive care units of the Kepler University Hospital, Linz, Austria between 2018-03-01 and 2020-10-31.

You may not qualify if:

  • None.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kepler University Hospital

Linz, Upper Austria, 4021, Austria

Location

Related Publications (1)

  • Tschoellitsch T, Kaltenleithner S, Maletzky A, Moser P, Seidl P, Bock C, Thumfart S, Giretzlehner M, Hochreiter S, Meier J. Mean arterial pressure is all you need in a machine learning model for mean arterial pressure prediction. Eur J Anaesthesiol. 2025 Dec 1;42(12):1112-1122. doi: 10.1097/EJA.0000000000002238. Epub 2025 Jul 7.

Study Officials

  • Thomas Tschoellitsch, MD

    Kepler University Hospital and Johannes Kepler University, Linz, Austria

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 12, 2022

First Posted

July 22, 2022

Study Start

June 1, 2022

Primary Completion

July 31, 2022

Study Completion

July 31, 2022

Last Updated

August 17, 2022

Record last verified: 2022-08

Data Sharing

IPD Sharing
Will not share

Locations